NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
06/12/2024
Back to search
Official data from USPTO
NORTHERA (DROXIDOPA) CAPSULES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
06/12/2024
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
02/29/2016
Registration date
09/19/2017
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/12/2024
Last transaction
06/12/2024
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Principal Register
First use anywhere
12/11/2014
First use in commerce
12/11/2014
Drawing code
3
Owner type
03
Owner location
Deerfield, IL
Examiner
DALIER,JOHN DAVID
Current location
Historical data usage
Mark description
The mark consists of the wording "NORTHERA" in slate grey on one line and "(DROXIDOPA) CAPSULES" in blue on another line below it. In the upper right are five slightly overlapping stylized figures of a person in slate grey, blue, grey, and light grey in an arc. The white background represents transparent areas only and is not a feature of the mark.
Holders and representatives
Holders
Lundbeck NA Ltd.
Representatives
Maren C. Perry King & Spalding LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the prevention and treatment of disorders and diseases ingenerated by or acting on the central nervous system; pharmaceutical preparations for the prevention and treatment of neurogenic orthostatic hypotension and for the prevention and treatment of low blood pressure; pharmaceutical preparations for the prevention and treatment of Parkinson's disease and disorder; pharmaceutical preparations for the prevention and treatment of dizziness and lightheadedness; all of the above-referenced goods containing in significant part DROXIDOPA
Publications
History of USPTO decisions and trademark events.
43 publications found
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
06/12/2024
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
06/11/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/22/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/22/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/22/2024
PRA8
POST REGISTRATION ACTION MAILED - SEC. 8
12/14/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/14/2023
ES8R
TEAS SECTION 8 RECEIVED
09/18/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
09/19/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
09/19/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08/12/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/11/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/17/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/17/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/13/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/13/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/13/2017
GNRT
NON-FINAL ACTION E-MAILED
01/13/2017
CNRT
SU - NON-FINAL ACTION - WRITTEN
01/13/2017
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/12/2017
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/12/2017
IUAF
USE AMENDMENT FILED
12/16/2016
EISU
TEAS STATEMENT OF USE RECEIVED
12/16/2016
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/06/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/11/2016
PUBO
PUBLISHED FOR OPPOSITION
10/11/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/21/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/07/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/30/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/30/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/30/2016
ALIE
ASSIGNED TO LIE
08/25/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/18/2016
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/11/2016
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/11/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/23/2016
GNRT
NON-FINAL ACTION E-MAILED
06/23/2016
CNRT
NON-FINAL ACTION WRITTEN
06/23/2016
DOCK
ASSIGNED TO EXAMINER
06/13/2016
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
03/04/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/03/2016
NWAP
NEW APPLICATION ENTERED
03/03/2016
Continuous trademark protection
Get notified about every new filing that threatens NORTHERA (DROXIDOPA) CAPSULES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.